In its largest-ever funding initiative for early-career researchers, the Academy of Medical Sciences is investing £7.6 million to tackle urgent health challenges from Alzheimer’s disease, cancer and obesity to addiction and climate change impacts.
Tecan Group has announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity.
MultiOmic Health and Alloy Therapeutics have announced they have signed a Memorandum of Understanding to jointly discover and develop first-in-class renal tissue-targeting drugs.
Olivia Friett, editor of European Pharmaceutical Manufacturer was invited to Hillerød, Denmark to see the first expansion of FUJIFILM Diosynth Biotechnologies’ facilities. Olivia spoke to Lars Peterson, president and CEO, about the expansion.
Zymewire has released its highly anticipated 2024 Biopharma Recap Report, offering data-driven insights into global biopharma funding, clinical trial activity, and biotech company formation over the prior year, based on data from biopharma companies.
medac Group has announced the commissioning of its latest investment: the third production line at oncomed, a production site in the Czech Republic operated by medac.
As a specialist in scalable, secure corporate payment solutions, B4B Payments continues to enhance its support for the pharmaceutical sector, offering innovative, compliance-friendly solutions to streamline operations and improve financial processes.
Likarda announced a new grant from the Gates Foundation that supports the company’s proprietary Core-Shell Spherification (CSS) system to extend the therapeutic potential of a cost-effective cell-based therapy for infectious diseases.
Chiesi Group, a biopharmaceutical company headquartered in Parma, Italy, has announced an investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions.
Avantor presented highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025.
Clinigen has announced that Equity Pharmaceuticals has entered into a new collaboration with Servier, an independent global pharmaceutical group, to enhance patient access to oncology and haematology medicines in South Africa.
